BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

751 related articles for article (PubMed ID: 31443616)

  • 1. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
    Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
    Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidisciplinary Outpatient Clinic of Neurocutaneous Diseases: Five-year Experience of a Pediatric Tertiary Hospital in Portugal.
    Rebelo M; Francisco T; Perry da Câmara R; Pereira A; Iraneta A; Amorim M; Paiva Lopes MJ; Lopes da Silva R; Cordeiro AI
    Acta Med Port; 2024 Mar; 37(3):187-197. PubMed ID: 37294265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analyses of mosaic neurofibromatosis type 1 with giant café-au-lait macule, plexiform neurofibroma and multiple melanocytic nevi.
    Hida T; Idogawa M; Okura M; Sugita S; Sugawara T; Sasaki Y; Tokino T; Yamashita T; Uhara H
    J Dermatol; 2020 Jun; 47(6):658-662. PubMed ID: 32246533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phakomatoses.
    Becker B; Strowd RE
    Dermatol Clin; 2019 Oct; 37(4):583-606. PubMed ID: 31466597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?
    Alkindy A; Chuzhanova N; Kini U; Cooper DN; Upadhyaya M
    Hum Genomics; 2012 Aug; 6(1):12. PubMed ID: 23244495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequencies of plexiform neurofibromas, mental retardation, learning difficulties, and scoliosis in Brazilian patients with neurofibromatosis type 1.
    Trovó-Marqui AB; Goloni-Bertollo EM; Valério NI; Pavarino-Bertelli EC; Muniz MP; Teixeira MF; Antonio JR; Tajara EH
    Braz J Med Biol Res; 2005 Sep; 38(9):1441-7. PubMed ID: 16138229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer.
    Hernández-Martín A; Duat-Rodríguez A
    Actas Dermosifiliogr; 2016; 107(6):465-73. PubMed ID: 26956402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidisciplinary neurocutaneous syndrome clinics: a systematic review and institutional experience.
    Grossen A; Gavula T; Chrusciel D; Evans A; McNall-Knapp R; Taylor A; Fossey B; Brakefield M; Carter C; Schwartz N; Gross N; Jea A; Desai V
    Neurosurg Focus; 2022 May; 52(5):E2. PubMed ID: 35535824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel NF1 mutation in a Chinese patient with giant café-au-lait macule in neurofibromatosis type 1 associated with a malignant peripheral nerve sheath tumor and bone abnormality.
    Tong HX; Li M; Zhang Y; Zhu J; Lu WQ
    Genet Mol Res; 2012 Aug; 11(3):2972-8. PubMed ID: 22869071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots, Freckling, and Neurofibromas. An Update. Part I. Dermatological Clinical Criteria Diagnostic of the Disease.
    Hernández-Martín A; Duat-Rodríguez A
    Actas Dermosifiliogr; 2016; 107(6):454-64. PubMed ID: 26979265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of a café-au-lait macules screening clinic: Experience from The Hospital for Sick Children in Toronto.
    Albaghdadi M; Berseneva M; Pennal A; Wan S; Matviychuk D; Shugar A; Kannu P; Lara-Corrales I
    Pediatr Dermatol; 2022 Mar; 39(2):205-210. PubMed ID: 35178768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mosaic Neurofibromatosis Type 1 in Children: A Single-Institution Experience.
    Lara-Corrales I; Moazzami M; García-Romero MT; Pope E; Parkin P; Shugar A; Kannu P
    J Cutan Med Surg; 2017; 21(5):379-382. PubMed ID: 28448720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and follow-up protocol for adult patients with neurofibromatosis type 1 in a Spanish reference unit.
    Solares I; Vinal D; Morales-Conejo M
    Rev Clin Esp (Barc); 2022 Oct; 222(8):486-495. PubMed ID: 35688675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicism.
    Legius E; Brems H
    Childs Nerv Syst; 2020 Oct; 36(10):2285-2295. PubMed ID: 32601904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Managing children with neurofibromatosis type 1: what should we look for?].
    Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
    Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients.
    Ars E; Kruyer H; Morell M; Pros E; Serra E; Ravella A; Estivill X; Lázaro C
    J Med Genet; 2003 Jun; 40(6):e82. PubMed ID: 12807981
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
    Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
    JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.
    Bernier A; Larbrisseau A; Perreault S
    Pediatr Neurol; 2016 Jul; 60():24-29.e1. PubMed ID: 27212418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hallazgos clínicos y epidemiológicos en la neurofibromatosis tipo 1 y el complejo esclerosis tuberosa en una serie de pacientes pediátricos].
    Cammarata-Scalisi F; Stock F; Velazco N; Silva GD; Lacruz-Rengel MA; Avendaño A
    Bol Med Hosp Infant Mex; 2018; 75(5):287-294. PubMed ID: 30250319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetics and diagnosis of pediatric neurocutaneous disorders: Neurofibromatosis and tuberous sclerosis complex.
    Tolliver S; Smith ZI; Silverberg N
    Clin Dermatol; 2022; 40(4):374-382. PubMed ID: 35248688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.